TA Phase IV Placebo-controlled Single Center Trial for Tirzepatide in Idiopathic Intracranial Hypertension Trial (TIIHT)," protocol I8F-NS-I004
Clinical Trial Grant
Administered By
Neurosurgery
Awarded By
Lilly USA, LLC
Start Date
October 1, 2025
End Date
September 30, 2033
Administered By
Neurosurgery
Awarded By
Lilly USA, LLC
Start Date
October 1, 2025
End Date
September 30, 2033